Status:
COMPLETED
Study of MK-0663/Etoricoxib in Postorthopedic Knee Replacement Surgery Pain (MK-0663-098)
Lead Sponsor:
Organon and Co
Conditions:
Pain, Postoperative
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The purpose of this study was to evaluate the efficacy and safety of Etoricoxib compared to placebo and ibuprofen in the treatment of postoperative pain associated with unilateral total knee replaceme...
Eligibility Criteria
Inclusion
- \- Is in generally good health and is scheduled to have a total knee replacement
Exclusion
- Is allergic, intolerant to, or has a history of a significant clinical or laboratory adverse experience associated with etoricoxib or other cyclooxygenase-2 (COX-2) inhibitors/non-steroidal anti-inflammatory drugs (NSAIDs), ibuprofen, morphine, or oxycodone, or has hypersensitivity to aspirin, or other NSAIDs
- Has uncontrolled hypertension
- Is currently a user of any illicit drugs, or has a history of drug or alcohol abuse within the past 5 years
Key Trial Info
Start Date :
December 15 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 14 2010
Estimated Enrollment :
776 Patients enrolled
Trial Details
Trial ID
NCT00820027
Start Date
December 15 2008
End Date
December 14 2010
Last Update
February 9 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.